Common Contracts

4 similar Amendment contracts by TNF Pharmaceuticals, Inc.

Amendment
Amendment • August 19th, 2024 • TNF Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

This Amendment (this “Amendment”), dated as of August [ ], 2024, is by and among TNF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).

AutoNDA by SimpleDocs
Amendment
Amendment • August 19th, 2024 • TNF Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

This Amendment (this “Amendment”), dated as of August [ ], 2024, is by and among TNF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).

Amendment
Amendment • August 19th, 2024 • TNF Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

This Amendment (this “Amendment”), dated as of August [ ], 2024, is by and among TNF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).

Amendment
Amendment • August 19th, 2024 • TNF Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

This Amendment (this “Amendment”), dated as of August [ ], 2024, is by and among TNF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!